These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 8873895)
1. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1. Werner H; Roberts CT; Rauscher FJ; LeRoith D J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Werner H; Shen-Orr Z; Rauscher FJ; Morris JF; Roberts CT; LeRoith D Mol Cell Biol; 1995 Jul; 15(7):3516-22. PubMed ID: 7791758 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Werner H; Re GG; Drummond IA; Sukhatme VP; Rauscher FJ; Sens DA; Garvin AJ; LeRoith D; Roberts CT Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5828-32. PubMed ID: 8390684 [TBL] [Abstract][Full Text] [Related]
5. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497 [TBL] [Abstract][Full Text] [Related]
6. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells. Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
9. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727 [TBL] [Abstract][Full Text] [Related]
10. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1. Zhang X; Xing G; Saunders GF Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095 [TBL] [Abstract][Full Text] [Related]
11. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Drummond IA; Madden SL; Rohwer-Nutter P; Bell GI; Sukhatme VP; Rauscher FJ Science; 1992 Jul; 257(5070):674-8. PubMed ID: 1323141 [TBL] [Abstract][Full Text] [Related]
12. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor. Tajinda K; Carroll J; Roberts CT Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530 [TBL] [Abstract][Full Text] [Related]
13. Functional properties of WT1. Haber DA; Englert C; Maheswaran S Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter. Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865 [TBL] [Abstract][Full Text] [Related]
15. RNA binding by the Wilms tumor suppressor zinc finger proteins. Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514 [TBL] [Abstract][Full Text] [Related]
16. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells. Nichols KE; Re GG; Yan YX; Garvin AJ; Haber DA Cancer Res; 1995 Oct; 55(20):4540-3. PubMed ID: 7553624 [TBL] [Abstract][Full Text] [Related]
17. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912 [TBL] [Abstract][Full Text] [Related]
18. The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein. Karnieli E; Werner H; Rauscher FJ; Benjamin LE; LeRoith D J Biol Chem; 1996 Aug; 271(32):19304-9. PubMed ID: 8702614 [TBL] [Abstract][Full Text] [Related]
19. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065 [TBL] [Abstract][Full Text] [Related]
20. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). Adachi Y; Matsubara S; Pedraza C; Ozawa M; Tsutsui J; Takamatsu H; Noguchi H; Akiyama T; Muramatsu T Oncogene; 1996 Nov; 13(10):2197-203. PubMed ID: 8950987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]